Clinical Analysis of Diabetic Combined Pulmonary Mucormycosis
Sign Up to like & getrecommendations! Published in 2017 at "Mycopathologia"
DOI: 10.1007/s11046-017-0167-z
Abstract: ObjectiveTo improve the understanding of diabetic combined pulmonary mucormycosis.Methods and ResultsThe clinical data of twelve patients diagnosed as diabetic combined pulmonary mucormycosis were analyzed by the clinical manifestations, imaging features, diagnosis, treatment and prognosis of… read more here.
Keywords: analysis diabetic; mucormycosis; clinical analysis; diabetic combined ... See more keywords
IFN-γ Mediated Signaling Improves Fungal Clearance in Experimental Pulmonary Mucormycosis
Sign Up to like & getrecommendations! Published in 2021 at "Mycopathologia"
DOI: 10.1007/s11046-021-00598-2
Abstract: We established three immunocompetent murine models of pulmonary mucormycosis to determine the involvement of the adaptive immune response in host resistance in pulmonary mucormycosis, a rapidly fatal disease caused mainly by Rhizopus spp. Immunocompetent inbred… read more here.
Keywords: mucormycosis; pulmonary mucormycosis; mice; ifn mediated ... See more keywords
Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature
Sign Up to like & getrecommendations! Published in 2021 at "Mycopathologia"
DOI: 10.1007/s11046-021-00610-9
Abstract: Literature on COVID-19-associated pulmonary mucormycosis (CAPM) is sparse. Pulmonary artery pseudoaneurysm (PAP) is an uncommon complication of pulmonary mucormycosis (PM), and rarely reported in CAPM. Herein, we report five cases of CAPM with PAP managed… read more here.
Keywords: mucormycosis; systematic review; literature; pulmonary mucormycosis ... See more keywords
Coinfection pulmonary mucormycosis and aspergillosis with disseminated mucormycosis involving gastrointestinalin in an acute B-lymphoblastic leukemia patient
Sign Up to like & getrecommendations! Published in 2021 at "Brazilian Journal of Microbiology"
DOI: 10.1007/s42770-021-00554-8
Abstract: Pulmonary mucormycosis and aspergillosis with disseminated mucormycosis involving gastrointestinalin is a very rare but lethal infection leading to extreme mortality. Herein, we present a unique case of pulmonary coinfection with Cunninghamella bertholletiae and Aspergillus flavus,… read more here.
Keywords: mucormycosis; mucormycosis involving; pulmonary mucormycosis; disseminated mucormycosis ... See more keywords
Challenges in the diagnosis of pulmonary mucormycosis in a diabetic with a review of literature
Sign Up to like & getrecommendations! Published in 2021 at "Respiratory Medicine Case Reports"
DOI: 10.1016/j.rmcr.2021.101474
Abstract: Diabetes Mellitus appears to be the most common underlying condition associated with mucormycosis; a rare opportunistic fungal infection associated with high morbidity and mortality. Pulmonary mucormycosis may mimic pneumonia and thus pose challenges in achieving… read more here.
Keywords: challenges diagnosis; mucormycosis diabetic; mucormycosis; pulmonary mucormycosis ... See more keywords
Outcomes after lung resection in renal transplant patients with pulmonary mucormycosis
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Transplantation"
DOI: 10.1111/ctr.14689
Abstract: Pulmonary mucormycosis has been associated with high mortality (reported up to 100%) in renal transplant recipients. read more here.
Keywords: pulmonary mucormycosis; outcomes lung; renal transplant; lung resection ... See more keywords
Treatment of pulmonary mucormycosis with adjunctive nebulized amphotericin B (MUCONAB trial): Results of an open-label randomized controlled trial.
Sign Up to like & getrecommendations! Published in 2023 at "Mycoses"
DOI: 10.1111/myc.13591
Abstract: BACKGROUND The role of nebulized amphotericin B (NAB) in managing pulmonary mucormycosis (PM) is unknown. METHODS In this open-label trial, we randomized PM subjects to receive either intravenous liposomal amphotericin B (control arm, 3-5 mg/kg/day) alone… read more here.
Keywords: day; nebulized amphotericin; amphotericin; trial ... See more keywords
Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus-A case-control study.
Sign Up to like & getrecommendations! Published in 2023 at "Mycoses"
DOI: 10.1111/myc.13604
Abstract: BACKGROUND Factors associated with pulmonary mucormycosis (PM) among subjects with diabetes mellitus (DM) remain unclear. Following the coronavirus disease (COVID-19)-associated mucormycosis outbreak in India, specific environmental exposures (especially cattle dung exposure) were proposed as possible… read more here.
Keywords: control; pulmonary mucormycosis; case; diabetes mellitus ... See more keywords
Pulmonary mucormycosis in immunocompetent hosts diagnosed by bronchioalveolar lavage
Sign Up to like & getrecommendations! Published in 2021 at "BMJ Case Reports"
DOI: 10.1136/bcr-2020-240180
Abstract: Mucormycosis is a rare infection caused by Mucorales fungi belonging to Zygomycetes class. It can present with spectrum of symptoms and signs based of organ involvement. Common forms of mucormycosis includes rhinocerebral, cutaneous, gastrointestinal, pulmonary,… read more here.
Keywords: mucormycosis immunocompetent; lavage; mucormycosis; immunocompetent hosts ... See more keywords
Clinical Manifestations of Pulmonary Mucormycosis in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: A 21-Case Series Report and Literature Review
Sign Up to like & getrecommendations! Published in 2022 at "Canadian Respiratory Journal"
DOI: 10.1155/2022/1237125
Abstract: Introduction Mucormycosis is a rare, invasive disease caused by opportunistic pathogens related to the Mucorales order with high fatality rates in immunocompromised hosts, especially in recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Diagnosis and… read more here.
Keywords: mucormycosis recipients; infection; pulmonary mucormycosis; allo hsct ... See more keywords
COVID associated pulmonary mucormycosis: Outcomes of surgical therapy
Sign Up to like & getrecommendations! Published in 2022 at "Asian Cardiovascular and Thoracic Annals"
DOI: 10.1177/02184923221140258
Abstract: Objectives This study aims at reporting the surgical outcomes of COVID associated pulmonary mucormycosis with special emphasis on surgical mortality. Methods This prospective observational study was conducted in a dedicated thoracic surgical unit in Gurugram,… read more here.
Keywords: therapy; pulmonary mucormycosis; mortality; covid associated ... See more keywords